GALECTIN THERAPEUTICS INC's ticker is GALT and the CUSIP is 363225202. A total of 72 filers reported holding GALECTIN THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 0.60 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2024 | $87,916 | +56.8% | 36,785 | +8.9% | 0.00% | – |
| Q4 2023 | $56,057 | -34.1% | 33,769 | -16.7% | 0.00% | – |
| Q1 2023 | $85,096 | +112.7% | 40,522 | +14.5% | 0.00% | – |
| Q4 2022 | $40,000 | -54.0% | 35,398 | -15.9% | 0.00% | – |
| Q4 2021 | $87,000 | -52.5% | 42,100 | -10.6% | 0.00% | – |
| Q3 2021 | $183,000 | +140.8% | 47,100 | +98.5% | 0.00% | – |
| Q2 2021 | $76,000 | -13.6% | 23,733 | -0.5% | 0.00% | – |
| Q3 2019 | $88,000 | -22.1% | 23,849 | +8.3% | 0.00% | – |
| Q1 2019 | $113,000 | +24.2% | 22,029 | +53.3% | 0.00% | – |
| Q2 2018 | $91,000 | -65.5% | 14,369 | -24.8% | 0.00% | -100.0% |
| Q2 2014 | $264,000 | +29.4% | 19,096 | +43.0% | 0.00% | +50.0% |
| Q1 2014 | $204,000 | – | 13,351 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Benchmark Capital Advisors | 221,700 | $1,051,000 | 0.83% |
| EAM Global Investors LLC | 227,063 | $1,076,000 | 0.56% |
| EAM Investors, LLC | 319,187 | $1,513,000 | 0.25% |
| COURAGE CAPITAL MANAGEMENT LLC | 30,000 | $142,000 | 0.11% |
| Cutter & CO Brokerage, Inc. | 53,600 | $254,000 | 0.10% |
| SABBY MANAGEMENT, LLC | 286,800 | $1,360,000 | 0.08% |
| D.A. DAVIDSON & CO. | 731,300 | $3,466,000 | 0.07% |
| Tibra Equities Europe Ltd | 63,414 | $301,000 | 0.05% |
| Advisor Group, Inc. | 556,377 | $2,637,000 | 0.04% |
| Laurel Wealth Advisors, Inc. | 21,400 | $101,000 | 0.03% |